Workflow
Euro
icon
Search documents
X @Bloomberg
Bloomberg· 2025-06-30 12:50
Moldova’s ruling pro-European party is leading in a new opinion poll three months ahead of a general election that’s crucial for maintaining the country’s course to join the EU https://t.co/FMjCg88ci0 ...
Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings
Globenewswire· 2025-06-30 12:00
SALT LAKE CITY, June 30, 2025 (GLOBE NEWSWIRE) -- Clene, Inc. (Nasdaq: CLNN) and its subsidiary, Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to advancing therapies for neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today provided a regulatory update following a Type C meeting with the U.S. Food and Drug Administration (FDA), and announced two additional meetings scheduled with the FDA in the 3rd quarter of 2025. In th ...
INmune Bio Reports Key Findings from Phase 2 MINDFuL Trial of XPro™ in Early Alzheimer's Disease
Globenewswire· 2025-06-30 11:30
In the Phase 2 MINDFuL trial of XPro™ in patients with early Alzheimer’s Disease (AD) with biomarkers of inflammation, the modified intent-to-treat (mITT) population (n=200) did not meet the primary cognitive endpoint (EMACC), however in a predefined population of amyloid-positive early AD patients with two or more biomarkers of inflammation (n=100), a benefit of XPro™ treatment over placebo was observed in cognitive, behavioral and biological endpoints. Treatment with XPro™ was well-tolerated and safe, eve ...
X @Bloomberg
Bloomberg· 2025-06-30 10:01
The bête noire of the European Union, Orban put his faith in Trump. So far it’s not working out https://t.co/Ag1P1ejm8L ...
Equity Risk Premium in Focus: 3-Minute MLIV
Bloomberg Television· 2025-06-30 07:12
If you're a US investor, U.S. equity markets are starting to look a little bit more rosy. We're on a decent roll. We're back.We've bounced quite strongly off the earlier lows. But if you're a European investor, the picture looks very different. How do I think about this. How are you thinking about this.Do you think this equity market rally has got legs. Well, I do think that the equity markets are looking a bit frothy guy, because, you know, since April we have bounced hard, as you mentioned. And if you loo ...
China-Europe Trade Relations: What to Expect From Wang Yi's Visit
Bloomberg Television· 2025-06-30 06:11
Lay out the visit for us then, Oli. The consequences, the importance of saying Wang Yi, the foreign Minister of China, on the ground in Europe. Yeah.So he's going to go to Brussels. He's going to go to Germany. He's going to go to France. He's going to meet with the foreign ministers of all of those countries, including the High representative.Kaja Kallas in Brussels, of course, and this is the first sort of high level meeting that you've had between the EU and China since the beginning of this new commissi ...
Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS
Prnewswire· 2025-06-30 06:00
NEW YORK, June 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of KLTO-202, its investigational gene therapy for amyotrophic lateral sclerosis (ALS).A unique RNA splice variant of the human gene called alpha-Klotho has been licensed by the Company from the Autonomous University of Barcelona ("UAB") including patents, patent applications, research, knowhow and other ...
X @Bloomberg
Bloomberg· 2025-06-29 19:05
A weak dollar and surging European stocks: what traders got right and wrong in 2025 https://t.co/zt5zjK60A9 ...
Immunic CEO discusses Phase 2 multiple sclerosis study success - ICYMI
Proactiveinvestors NA· 2025-06-28 13:05
Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt talked with Proactive about new positive data from the company’s phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting multiple sclerosis (RRMS). Proactive: Hello you're watching Proactive, I'm joined by Immunic CEO Dr Daniel Vitt. Daniel, very good to speak with you. You reported positive data from your phase 2 EMPhASIS trial of vidofludimus calcium in relapsing remitting multiple sclerosis. The data shows a low rate of confirmed disability worse ...
X @Bloomberg
Bloomberg· 2025-06-27 10:38
Spanish Economy Minister Carlos Cuerpo is running to lead the Eurogroup of euro-zone finance ministers https://t.co/TxUCBnMeJW ...